Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Arch TherapeuticsTitan MedicalNephrosInvo BioscienceT2 Biosystems
SymbolOTCMKTS:ARTHNASDAQ:TMDIN/AOTCMKTS:IVOBNASDAQ:TTOO
Price Information
Current Price$0.16$0.53N/A$0.28$2.54
52 Week RangeBuyBuyN/AN/ABuy
Analyst Ratings
Consensus RecommendationBuyBuyN/AN/ABuy
Consensus Price Target$1.88$6.67N/AN/A$5.61
% Upside from Price Target1,051.01% upside1,156.44% upsideN/AN/A120.96% upside
Trade Information
Market Cap$27.36 million$11.77 million$47.94 million$46.68 million$116.24 million
Beta0.114.830.85-0.731.21
Average Volume531,684708,0473,98553,266696,811
Sales & Book Value
Annual RevenueN/AN/A$5.69 million$490,000.00$10.50 million
Price / SalesN/AN/A0.0088.4410.77
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.01 per share$0.19 per share$0.95 per share($0.02) per share$0.26 per share
Price / BookN/AN/A0.00-13.939.77
Profitability
Net Income$-4,810,000.00$-22,640,000.00$-3,400,000.00$-3,080,000.00$-51,150,000.00
EPSN/A($1.36)($0.54)N/A($1.26)
Trailing P/E Ratio0.00N/AN/A0.00N/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-52.25%-156.65%-722.70%
Return on Equity (ROE)-6,477.65%N/A-56.46%N/A-1,263.94%
Return on Assets (ROA)-140.10%-91.59%-36.62%-82.32%-94.15%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.21%N/AN/A
Current Ratio13.98%0.50%2.31%1.39%0.58%
Quick Ratio13.99%0.50%1.65%1.36%0.52%
Ownership Information
Institutional Ownership Percentage0.04%8.73%N/AN/A38.21%
Insider Ownership PercentageN/AN/A6.80%N/A30.30%
Miscellaneous
Employees89182153
Shares Outstanding172.61 million21.67 million7.67 million155.60 million44.54 million
Next Earnings Date11/7/2019 (Estimated)11/11/2019 (Estimated)N/A11/13/2019 (Estimated)11/7/2019 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable
 Arch TherapeuticsTitan MedicalNephrosInvo BioscienceT2 Biosystems

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel